Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.23B | 56.40B | 52.07B | 44.25B | 37.86B | 34.72B |
Gross Profit | 15.68B | 15.60B | 14.74B | 12.09B | 9.76B | 9.73B |
EBITDA | 7.72B | 7.80B | 7.32B | 4.75B | 3.11B | 4.05B |
Net Income | 3.94B | 4.45B | 4.01B | 2.35B | 1.28B | 2.19B |
Balance Sheet | ||||||
Total Assets | 72.45B | 73.90B | 68.04B | 59.94B | 52.42B | 48.57B |
Cash, Cash Equivalents and Short-Term Investments | 17.58B | 17.61B | 13.21B | 11.36B | 11.77B | 13.03B |
Total Debt | 3.86B | 3.26B | 3.29B | 2.97B | 1.42B | 2.02B |
Total Liabilities | 22.14B | 22.46B | 21.25B | 19.31B | 14.55B | 13.72B |
Stockholders Equity | 50.31B | 51.43B | 46.79B | 40.58B | 37.83B | 34.82B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.48B | 1.42B | -2.09B | -806.99M | 2.55B |
Operating Cash Flow | 0.00 | 8.33B | 3.82B | -663.79M | 39.92M | 3.42B |
Investing Cash Flow | 0.00 | -3.19B | -2.42B | -1.31B | -933.75M | -928.13M |
Financing Cash Flow | 0.00 | -743.17M | -212.61M | 1.20B | -923.15M | -1.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥17.15B | 7.24 | 1.13% | 3.43% | 16.71% | ||
79 Outperform | ¥12.21B | 5.96 | 1.55% | 12.17% | 63.70% | ||
79 Outperform | ¥13.59B | 8.71 | 5.34% | 3.96% | 482.92% | ||
78 Outperform | ¥39.29B | 9.87 | 2.05% | -0.70% | -17.98% | ||
75 Outperform | ¥48.53B | 10.90 | 1.13% | 8.33% | 10.87% | ||
71 Outperform | ¥12.43B | 23.23 | 6.78% | -17.95% | -83.01% | ||
62 Neutral | C$6.62B | 7.59 | 3.42% | 2.82% | 6.67% | -16.67% |